|
JUB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.778400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.630400E-01 |
| Normal-vs-Stage2 |
6.401700E-04 |
| Normal-vs-Stage3 |
4.3030000000055E-05 |
| Normal-vs-Stage4 |
5.428800E-04 |
| Stage1-vs-Stage2 |
1.457910E-03 |
| Stage1-vs-Stage3 |
6.05839999999747E-05 |
| Stage1-vs-Stage4 |
1.159390E-03 |
| Stage2-vs-Stage3 |
7.794200E-01 |
| Stage2-vs-Stage4 |
7.512200E-01 |
| Stage3-vs-Stage4 |
9.256600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.980800E-03 |
| Normal-vs-AfricanAmerican |
3.979700E-03 |
| Normal-vs-Asian |
6.764800E-01 |
| Caucasian-vs-AfricanAmerican |
2.260000E-01 |
| Caucasian-vs-Asian |
1.755820E-01 |
| AfricanAmerican-vs-Asian |
9.310100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.897300E-03 |
| Normal-vs-Female |
5.753500E-02 |
| Male-vs-Female |
1.959250E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.296500E-03 |
| Normal-vs-Age(41-60Yrs) |
3.103700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.198460E-02 |
| Normal-vs-Age(81-100Yrs) |
5.267900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.614160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.177200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.568800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.550400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.063200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.229400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.195400E-01 |
| Normal-vs-Grade 2 |
1.621790E-01 |
| Normal-vs-Grade 3 |
1.743630E-02 |
| Normal-vs-Grade 4 |
1.21430000055156E-07 |
| Grade 1-vs-Grade 2 |
1.396390E-01 |
| Grade 1-vs-Grade 3 |
5.012100E-02 |
| Grade 1-vs-Grade 4 |
3.84970000000262E-05 |
| Grade 2-vs-Grade 3 |
1.481760E-01 |
| Grade 2-vs-Grade 4 |
2.78809999976204E-07 |
| Grade 3-vs-Grade 4 |
1.376530E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.615000E-01 |
| Normal-vs-ccB subtype |
2.88119994529268E-09 |
| ccA subtype-vs-ccB subtype |
1.62447832963153E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.516800E-03 |
| Normal-vs-N1 |
1.06170000002681E-06 |
| N0-vs-N1 |
8.210300E-04 |
|
|
